New Research on Memantine Market - Side Effects, Drug Interactions, Warning and precautions | Detailed Study by Coherent Market Insights with Upcoming Trends

Global Memantine Market Analysis

Overview

Memantine is a non-acetyl cholinesterase inhibitor that helps in Alzheimer's disease therapy. The medicine was approved for sale in Europe in 2002 and the United States Food and Drug Administration (US FDA) in 2003. Since 2015, generic versions of the medications have become accessible. Memantine is used to cure Alzheimer's disease-related dementia, which ranges from mild to severe. Although, chronic use of the medication may result in a serious skin response known as Stevens-Johnson syndrome (characterized by painful blisters on the skin).

Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2255

Drivers

The global memantine market is forecast to rise as the quantity of pipeline studies for its application grows. In September 2016, Lille University Hospital began a phase I clinical trial to evaluate the effects of memantine on cognitive behavior in Alzheimer's disease patients. The research is expected to be finished in February 2019.

Suven Life Sciences Limited is also conducting a phase II clinical trial to compare the safety and effectiveness of SUVN-502 to memantine HCl and donezepil HCl in the treatment of mild Alzheimer's disease. The research began in September 2015 and is slated to end in May 2019.

Restraint

The growing number of pharmacological licenses that have expired is a key stumbling block to the global memantine market's expansion. As per Merz Pharmaceuticals, a German firm, overall license revenues for memantine during the patented period declined in October 2018 owing to the end of patent protection in the majority of markets. As per Merz Pharmaceuticals, memantine license revenue in the U.S. fell to US$ 138.07 million in 2017-18, down from US$ 183.34 million the previous year.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2255

Regional Insights

Due to the growing number of generic versions of memantine in the U.S. market, North America is projected to keep a dominating position in the global memantine market. Lupin Limited announced the introduction of its Memantine Hydrochloride Extended-Release Capsules in the United States in February 2018. The capsules come in seven different strengths: 28 milligrams, 21 milligrams, 14 milligrams, and 7 milligrams. These are for the treatment of Alzheimer's disease dementia, which ranges from mild to severe.

Moreover, due to major companies' increased focus on producing memantine tablets, Asia Pacific is projected to see considerable growth in the global memantine market. Dr. Reddy's Laboratories introduced memantine hydrochloride tablets to the Indian market in October 2018. They come in doses of 5 milligrams and 10 milligrams, and are generic versions of Namenda pills that were already on the market in July 2015.

Special Requirements?

We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2255

Competitive Landscape

Major companies contributing in the global memantine market are Ono Pharmaceutical Co Ltd., H. Lundbeck A/S, Novartis AG, Lupin Limited, Merz Pharmaceuticals, Johnson & Johnson Services, Inc., Allergan plc., Daiichi Sankyo Company, Dr. Reddy’s Laboratories, and Eisai Co.

Table of Content

Global Memantine Market Research Report

Section 1: Global Memantine Industry Overview

Section 2:  Global Economic Impact on Memantine Industry

Section 3:  Global Market Competition by Industry Producers

Section 4:  Global Productions, Revenue (Value), according to Regions

Section 5:  Global Supplies (Production), Consumption, Export, Import, geographically

Section 6:  Global Productions, Revenue (Value), Price Trend, Product Type

Section 7:  Global Market Analysis, on the basis of Application

Section 8:  Memantine Market Pricing Analysis

Section 9:  Market Chain, Sourcing Strategy and Downstream Buyers

Section 10:  Strategies and key policies by Distributors/Suppliers/Traders

Section 11:  Key Marketing Strategy Analysis, by Market Vendors

Section 12:  Market Effect Factors Analysis

Section 13:  Global Memantine Market Forecast

Other Related News:

AMINO ACID ANALYZER MARKET ANALYSIS

XEROSTOMIA THERAPEUTICS MARKET ANALYSIS

HUMAN COMBINATION VACCINES MARKET ANALYSIS

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837